Find, organize, attend, and make the most of Oncology & Hematology events worldwide

OncoSystem Directory

Explore organizations in the global Oncology ecosystem

908 organization(s) found

Company

Pfizer

New York, NY, United States
Website
Hospital

PGIMER - Postgraduate Institute of Medical Education and Research

Chandigarh, India
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

Pheon Therapeutics

Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat difficult-to-treat solid tumors.

ADCs for Oncology
London, United Kingdom
Drug Discovery & DevelopmentCancer TherapeuticsBiologicsConjugatesADCsSolid Tumors
Website
Company

Phillips Healthcare

At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.

Medical Imaging, Medical Devices, Medical Equipment, Healthcare IT Services
Amsterdam, Netherlands
Website
Company

Pierre Fabre

We take care of life by designing and developing innovative solutions inspired by consumers and patients and contributing to the well-being of everyone from health to beauty. We achieve this by cooperating with health-care professionals, our trusted partners worldwide, by drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations.

Oncology, Dermatology, Onco-dermatology, OTC, Cosmetics
Castres, France
Website
Patient Advocacy Group

PinkDrive – South Africa

Organisation focusing on cancer (especially women’s cancers) awareness, screening and early detection campaigns in South Africa. (From list of cancer NGOs in South Africa.)(canceralliance.org.za)

Randburg, South Africa
Patient AdvocacyPatient CareClinical CareEducationPublic Health
Website
Company

Pinot Bio

Pinotbio is a biotech company developing new treatments for patients resistant to existing therapies based on innovative new drug modalities such as antibody-drug conjugates (ADCs). Based on our strong R&D capabilities, we have built our next-generation ADC platform, PINOT-ADC� independently and have been working with various partners to research new ADC anticancer treatments.

ADCs and small-molecules for Oncology
Yeongtong-gu, Suwon-si, Gyeonggi-do, South Korea
Drug Discovery & DevelopmentCancer TherapeuticsSmall-Molecule DrugsBiologicsConjugatesADCsBlood Cancers
Website
Company

PMV Pharmaceuticals

At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

Small-molecule drugs targeting mutated p53 and other targets in Oncology
Princeton, NJ, United States
Drug Discovery & DevelopmentSmall-Molecule DrugsSolid TumorsBlood Cancersp53
Website
Hospital

Policlinico di Sant'Orsola-Malpighi

Bologna, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Policlinico Umberto I

Rome, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Policlinico Universitario A. Gemelli

Rome, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Other

Prague Metabolism Symposium

The group that organizes the Prague Metabolism and Signaling Symposium

Prague, Czech Republic
MetabolismMolecular & Cell BiologyBasic ResearchFundamental ResearchEducationTraining
Website
Company

Predicta Biosciences

Advanced biopsy and reporting technology: Our approach delivers unprecedented sensitivity, accuracy, and informativity for diagnostics of multiple myeloma and other plasma cell dyscrasias. Our platform leverages whole genome sequencing (WGS) of cells isolated from both bone marrow and blood, providing significantly enhanced sensitivity and a wealth of diagnostic information compared to traditional bone marrow FISH assays. This enables more accurate diagnoses and earlier disease intervention.

Precision Diagnostics for Blood Cancers
Cambridge, MA, United States
DiagnosticsPrecision OncologyGenomicsBlood CancersHemato-OncologyMyeloma
Website
Hospital

Presidio Ospedaliero Spedali Civili di Brescia

Brescia, Italy
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Hospital

Princess Máxima Center

The Princess Máxima Center is not an ordinary hospital, but a research hospital. All children with cancer in the Netherlands are treated here. This makes the Princess Máxima Center the largest pediatric cancer center in Europe. Over 600 researchers and 900 healthcare professionals work closely with Dutch and international hospitals on better treatments and new perspectives on cures. In this way, we give the child of today the very best care and take important steps to improve the chances of survival for the children who are not yet cured.

Pediatric Oncology
Utrecht, Netherlands
Pediatric OncologyChildrenAdolescentsHospitalClinical CareSolid TumorsBlood Cancers
Website
Company

Priothera

Extending and enhancing the quality of life and radically transforming the treatment of patients with hematological malignancies

Small-molecule drugs and CAR-T therapies for treatment of Leukemia, Autoimmune Disorders and other diseases
Saint-Louis, France
Website
Company

ProEn Therapeutics

ProEn Therapeutics Inc. is a new drug development company that focuses on oncology, and that contributes to the healthy life of mankind through biopharmaceuticals developed for protein engineering.

Bispecific ADCs, immune-cell engagers and CAR therapies for Oncology
Sujeong-gu, Seongnam-si, Gyeonggi-do, South Korea
Drug Discovery & DevelopmentCancer TherapeuticsBiologicsProtein EngineeringConjugatesADCsImmune-Cell Engager
Website
Patient Advocacy Group

Project Pink Blue – Nigera

Nonprofit engaged in raising cancer awareness, patient navigation, advocacy and free breast and cervical cancer screening; launched Nigeria’s first patient-navigation service and toll-free cancer hotline.

Abuja, Nigeria
Patient AdvocacyPatient CareClinical CareEducationPublic Health
Website
Hospital

Providence St. Jude Medical Center

Fullerton, United States
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

Providence Therapeutics

Providence Therapeutics is an mRNA medicines company developing transformative cancer immunotherapies and protection from hard-to-treat infectious diseases. Our therapeutics come from a fully integrated, end-to-end Research and Development Ecosystem combining target discovery, our proprietary mRNA platform, INTENT� lipid nanoparticle platform (LNP), and a proven mRNA-LNP manufacturing platform applicable to fully personalized medicine all the way to pandemic scale manufacturing.

mRNA cancer vaccines and immunotherapies
Calgary, AB, Canada
Website
Biocluster / Regional Development Agency

PSCC

The Paris Saclay Cancer Cluster (PSCC) is an internationally renowned biocluster to accelerate oncology innovation

Innovation
Villejuif, France
BioclusterInnovationHubEventsCommunicationsStart-ups
Website
Public Health / Government Agency

Qidong Liver Cancer Institute / Qidong Cancer Registry

Focused on liver-cancer epidemiology and registry; represents regionally oriented cancer surveillance and research outside major megacities. (publications.iarc.who.int)

Qidong, China
Cancer ResearchCancer ControlEpidemiologyPublic Health
Website
Hospital

Queen Elizabeth Hospital Birmingham

Birmingham, United Kingdom
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

Qure Biotechnology

QureBio Ltd. was established in July 2017 and aims to develop novel therapeutic drugs for the treatment of tumors, autoimmune diseases and metabolic diseases in China and around the world to benefit patients. The company has multiple technology platforms for antibody drug development including phage display, hybridoma as well as protein and antibody engineering. In addition, the company's goal is to make an effective and robust manufacturing process for biologics.

Macromolecular drugs for Oncology (solid tumors amd blood cancers), Autoimmune Diseases and Metabolic Diseases
Shanghai, China
Drug Discovery & DevelopmentBiologicsmAbsBispecificsTripecificsSolid TumorsBlood Cancers
Website